US FDA pauses Gilead trials testing experimental HIV pill combination
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| Gilead Sciences (NASDAQ: GILD) | Delayed: 153.54 +5.62 (3.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.92 | 52 Week High | $108.63 | |||
| Open | $148.19 | 52 Week Low | $71.39 | |||
| Day High | $153.76 | P/E | 84.83 | |||
| Day Low | $147.48 | EPS | $1.81 | |||
| Volume | 5,760,048 | |||||
